Tinnitus Centralthe latest tinnitus news from all over the net

News from Medical Express

Discovery of new neurons in the inner ear can lead to new therapies for hearing disorders

Researchers at Karolinska Institutet in Sweden have identified four types of neurons in the peripheral auditory system, three of which are new to science. The analysis of these cells can lead to new therapies for various kinds of hearing disorders, such as tinnitus and age-related hearing loss. The study is published in Nature Communications.

Source: Medical Express
Published: Wed, 12 Sep 2018 07:24 UTC

Risk of cochlear disorders up with history of migraine

(HealthDay)—The risk of cochlear disorders, especially tinnitus, is increased among patients with a history of migraine, according to a study published online July 12 in JAMA Otolaryngology-Head & Neck Surgery.

Source: Medical Express
Published: Wed, 18 Jul 2018 15:00 UTC

Mindfulness is key to tinnitus relief

A leading UK study has found that a new mindfulness based approach to tinnitus could transform the treatment of the condition.

Source: Medical Express
Published: Mon, 02 Jul 2018 07:00 UTC

Study suggests brainwave link between disparate disorders

A brainwave abnormality could be a common link between Parkinson's disease, neuropathic pain, tinnitus and depression—a link that authors of a new study suggest could lead to treatment for all four conditions.

Source: Medical Express
Published: Thu, 24 May 2018 07:51 UTC

Mifepristone may halt growth of intracranial tumor that causes hearing loss

Massachusetts Eye and Ear researchers have shown that mifepristone, a drug currently FDA-approved for chemical abortion, prevents the growth of vestibular schwannoma (also known as acoustic neuroma) cells. This sometimes-lethal intracranial tumor typically causes hearing loss and tinnitus. The findings, published online today in Scientific Reports, suggest that mifepristone is a promising drug candidate to be repositioned for the treatment of these tumors.

Source: Medical Express
Published: Tue, 03 Apr 2018 12:31 UTC

Specially timed signals ease tinnitus symptoms in first test aimed at condition's root cause

Millions of Americans hear ringing in their ears—a condition called tinnitus—but a new study shows an experimental device could help quiet the phantom sounds by targeting unruly nerve activity in the brain.

Source: Medical Express
Published: Wed, 03 Jan 2018 14:00 UTC

Mindfulness—a new treatment for tinnitus

A randomized controlled trial published in the current issue of Psychotherapy and Psychosomatics discloses the effectiveness of mindfulness-based cognitive therapy as a treatment for chronic tinnitus. Tinnitus is experienced by up to 15% of the population and can lead to significant disability and distress. There is rarely a medical or surgical target and psychological therapies are recommended.

Source: Medical Express
Published: Wed, 03 Jan 2018 09:20 UTC

Neurofeedback shows promise in treating tinnitus

Researchers using functional MRI (fMRI) have found that neurofeedback training has the potential to reduce the severity of tinnitus or even eliminate it, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

Source: Medical Express
Published: Mon, 27 Nov 2017 05:43 UTC

Bilateral tinnitus in men may be hereditary

European researchers have discovered that genetic factors play a role in some cases of tinnitus, particularly in men who have the condition in both ears.

Source: Medical Express
Published: Mon, 20 Nov 2017 09:20 UTC

Medial temporal lobe surgery linked to prevalence of tinnitus

(HealthDay)—Patients with epilepsy undergoing medial temporal lobe (MTL) surgery have increased prevalence of tinnitus compared with controls and participants with self-reported epilepsy (SRE), according to a research letter published online Oct. 9 in JAMA Neurology.

Source: Medical Express
Published: Tue, 10 Oct 2017 14:10 UTC



By clicking on "Agree" you give Tinnitus Central permission to store and process cookies in accordance with our privacy and cookie statement.


RejectAgree